151 related articles for article (PubMed ID: 37737377)
1. VEGF Secretion Drives Bone Formation in Classical MAP2K1+ Melorheostosis.
Allbritton-King JD; Maity J; Patel A; Colbert RA; Navid F; Bhattacharyya T
J Bone Miner Res; 2023 Dec; 38(12):1834-1845. PubMed ID: 37737377
[TBL] [Abstract][Full Text] [Related]
2. Somatic activating mutations in MAP2K1 cause melorheostosis.
Kang H; Jha S; Deng Z; Fratzl-Zelman N; Cabral WA; Ivovic A; Meylan F; Hanson EP; Lange E; Katz J; Roschger P; Klaushofer K; Cowen EW; Siegel RM; Marini JC; Bhattacharyya T
Nat Commun; 2018 Apr; 9(1):1390. PubMed ID: 29643386
[TBL] [Abstract][Full Text] [Related]
3. Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.
Jha S; Fratzl-Zelman N; Roschger P; Papadakis GZ; Cowen EW; Kang H; Lehky TJ; Alter K; Deng Z; Ivovic A; Flynn L; Reynolds JC; Dasgupta A; Miettinen M; Lange E; Katz J; Klaushofer K; Marini JC; Siegel RM; Bhattacharyya T
J Bone Miner Res; 2019 Jan; 34(1):145-156. PubMed ID: 30138550
[TBL] [Abstract][Full Text] [Related]
4. Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.
Kang H; Jha S; Ivovic A; Fratzl-Zelman N; Deng Z; Mitra A; Cabral WA; Hanson EP; Lange E; Cowen EW; Katz J; Roschger P; Klaushofer K; Dale RK; Siegel RM; Bhattacharyya T; Marini JC
J Exp Med; 2020 May; 217(5):. PubMed ID: 32232430
[TBL] [Abstract][Full Text] [Related]
5. Melorheostotic Bone Lesions Caused by Somatic Mutations in MAP2K1 Have Deteriorated Microarchitecture and Periosteal Reaction.
Fratzl-Zelman N; Roschger P; Kang H; Jha S; Roschger A; Blouin S; Deng Z; Cabral WA; Ivovic A; Katz J; Siegel RM; Klaushofer K; Fratzl P; Bhattacharyya T; Marini JC
J Bone Miner Res; 2019 May; 34(5):883-895. PubMed ID: 30667555
[TBL] [Abstract][Full Text] [Related]
6. A multi-omics approach expands the mutational spectrum of MAP2K1-related melorheostosis.
De Ridder R; Boudin E; Zillikens MC; Ibrahim J; van der Eerden BCJ; Van Hul W; Mortier G
Bone; 2020 Aug; 137():115406. PubMed ID: 32387835
[TBL] [Abstract][Full Text] [Related]
7. Fibroblasts from Patients with Melorheostosis Promote Angiogenesis in Healthy Endothelial Cells through Secreted Factors.
Hurley-Novatny AC; Allbritton-King JD; Jha S; Cowen EW; Colbert RA; Navid F; Bhattacharyya T
J Invest Dermatol; 2022 Sep; 142(9):2406-2414.e5. PubMed ID: 35189151
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization.
Fowlkes JL; Bunn RC; Ray PD; Kalaitzoglou E; Uppuganti S; Unal M; Nyman JS; Thrailkill KM
Bone; 2020 Jan; 130():115106. PubMed ID: 31689526
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of 10 Chinese patients with melorheostosis and identification of a somatic MAP2K1 variant in one case.
Han X; Xu Y; Wei Z; Wang C; Yue H; Zhang Z
Mol Genet Genomic Med; 2022 Oct; 10(10):e2043. PubMed ID: 36004822
[TBL] [Abstract][Full Text] [Related]
10. Melorheostosis and Osteopoikilosis: A Review of Clinical Features and Pathogenesis.
Wordsworth P; Chan M
Calcif Tissue Int; 2019 May; 104(5):530-543. PubMed ID: 30989250
[TBL] [Abstract][Full Text] [Related]
11. Distribution and Functional Consequences of Somatic MAP2K1 Variants in Affected Skin Associated with Bone Lesions in Melorheostosis.
Jha S; Ivovic A; Kang H; Meylan F; Hanson EP; Rimland C; Lange E; Katz J; McBride A; Warner AC; Edmondson EF; Cowen EW; Marini JC; Siegel RM; Bhattacharyya T
J Invest Dermatol; 2021 Mar; 141(3):688-692.e11. PubMed ID: 32791068
[No Abstract] [Full Text] [Related]
12. A TGF-beta-inducible cell adhesion molecule, betaig-h3, is downregulated in melorheostosis and involved in osteogenesis.
Kim JE; Kim EH; Han EH; Park RW; Park IH; Jun SH; Kim JC; Young MF; Kim IS
J Cell Biochem; 2000 Mar; 77(2):169-78. PubMed ID: 10723084
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic antibody directed osteogenic differentiation of induced pluripotent stem cell derived MSCs.
Wu Q; Yang B; Cao C; Hu K; Wang P; Man Y
Acta Biomater; 2018 Jul; 74():222-235. PubMed ID: 29778895
[TBL] [Abstract][Full Text] [Related]
14. Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature.
Spitzhorn LS; Megges M; Wruck W; Rahman MS; Otte J; Degistirici Ö; Meisel R; Sorg RV; Oreffo ROC; Adjaye J
Stem Cell Res Ther; 2019 Mar; 10(1):100. PubMed ID: 30885246
[TBL] [Abstract][Full Text] [Related]
15. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors.
Layh-Schmitt G; Lu S; Navid F; Brooks SR; Lazowick E; Davis KM; Montagna C; Gadina M; Colbert RA
Clin Rheumatol; 2017 Jan; 36(1):143-154. PubMed ID: 27864696
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Modelling of Osteogenesis Imperfecta with Patient-Derived Induced Mesenchymal Stem Cells.
Claeys L; Zhytnik L; Ventura L; Wisse LE; Eekhoff EMW; Pals G; Bravenboer N; Heine VM; Micha D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542391
[TBL] [Abstract][Full Text] [Related]
17. Low-Intensity Pulsed Ultrasound Promotes Osteogenic Potential of iPSC-Derived MSCs but Fails to Simplify the iPSC-EB-MSC Differentiation Process.
Hua Z; Li S; Liu Q; Yu M; Liao M; Zhang H; Xiang X; Wu Q
Front Bioeng Biotechnol; 2022; 10():841778. PubMed ID: 35656194
[TBL] [Abstract][Full Text] [Related]
18. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice.
Hu GW; Li Q; Niu X; Hu B; Liu J; Zhou SM; Guo SC; Lang HL; Zhang CQ; Wang Y; Deng ZF
Stem Cell Res Ther; 2015 Apr; 6(1):10. PubMed ID: 26268554
[TBL] [Abstract][Full Text] [Related]
19. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of mouse-induced pluripotent stem cells and mesenchymal stem cells during osteogenic differentiation in vitro.
Egusa H; Kayashima H; Miura J; Uraguchi S; Wang F; Okawa H; Sasaki J; Saeki M; Matsumoto T; Yatani H
Stem Cells Dev; 2014 Sep; 23(18):2156-69. PubMed ID: 24625139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
